DeQuattro Community Cancer Center

Manchester, Connecticut 06040

0 studies enrolling now · 2 studies all time

What they study most

Hormone Refractory Prostate Cancer, Pancreatic Cancer, Prostate Cancer

Studies at this site

• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed